RxDoctor Payments Data

Fray Arroyo Mercado, MD

Gastroenterology · Manati, PRNPI 1114471489

Payments from drug & device makers

What this record shows

19 manufacturers reported payments, led by Boston Scientific at 32.6% of the total. Reporting peaked in 2024 at $3,753 and has fallen 93.9% since, to $231 in 2025.

$7,641in general payments, 2019–2025

Across 104 payments — averaging $73.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Olympus Corporation Of The Americas$2K
  • AbbVie$825
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$556
  • Takeda Pharmaceuticals U.S.A., Inc.$529
  • Wilson Cook Medical Incorporated$469
  • plus $921 from 13 others

What the payments were for

  • Travel & lodging$4,16054%
  • Food & beverage$3,48146%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,641 in reported general payments places this provider in the 85th percentile of 198 gastroenterology providers in Puerto Rico.

See all gastroenterology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$11,494
Medicare patients
72
Services billed
105

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole54$1,294
Ondansetron Hcl17$265
Dicyclomine Hcl11$245
Famotidine13$70

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Manati

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →